• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A controlled comparison of four regimens of streptomycin plus pyrazinamide in the retreatment of pulmonary tuberculosis.

出版信息

Tubercle. 1969 Jun;50(2):81-114. doi: 10.1016/0041-3879(69)90017-8.

DOI:10.1016/0041-3879(69)90017-8
PMID:4892324
Abstract
摘要

相似文献

1
A controlled comparison of four regimens of streptomycin plus pyrazinamide in the retreatment of pulmonary tuberculosis.链霉素联合吡嗪酰胺四种方案用于肺结核复治的对照比较
Tubercle. 1969 Jun;50(2):81-114. doi: 10.1016/0041-3879(69)90017-8.
2
Streptomycin plus PAS plus pyrazinamide in the retreatment of pulmonary tuberxulisis in East Africa.链霉素加对氨基水杨酸加吡嗪酰胺用于东非肺结核复治
Tubercle. 1971 Sep;52(3):191-8. doi: 10.1016/0041-3879(71)90042-0.
3
Controlled clinical trial of short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis.
Lancet. 1972 May 20;1(7760):1079-85.
4
Controlled clinical trial of four short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis.
Lancet. 1974 Nov 9;2(7889):1100-6.
5
A four-year follow-up of patients with quiescent pulmonary tuberculosis at the end of a year of chemotherapy with twice-weekly isoniazid plus streptomycin or daily isoniazid plus pas.对采用异烟肼加链霉素每周两次或异烟肼加对氨基水杨酸每日一次进行为期一年化疗结束时处于静止期的肺结核患者进行的四年随访。
Tubercle. 1969 Jun;50(2):115-24. doi: 10.1016/0041-3879(69)90018-x.
6
Streptomycin plus pyrazinamide in the retreatment of pulmonary tuberculosis--second report. A co-operative study in East African hospitals, clinics and laboratories with the collaboration of the East African and British Medical Research Councils.链霉素加吡嗪酰胺用于肺结核复治——第二次报告。东非医院、诊所和实验室与东非医学研究委员会和英国医学研究委员会合作开展的一项联合研究。
Tubercle. 1970 Dec;51(4):359-74.
7
Controlled trial of 6- and 9-month regimens of daily and intermittent streptomycin plus isoniazid plus pyrazinamide for pulmonary tuberculosis in Hong Kong.香港采用每日及间歇使用链霉素加异烟肼加吡嗪酰胺的6个月和9个月疗程治疗肺结核的对照试验。
Tubercle. 1975 Jun;56(2):81-96. doi: 10.1016/0041-3879(75)90020-3.
8
Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, three-times-weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council.对痰涂片阳性肺结核患者采用每周三次、为期6个月的治疗方案，比较2个月、4个月和6个月吡嗪酰胺使用时间的对照试验，包括对异烟肼、利福平及吡嗪酰胺复方制剂的评估。30个月时的结果。香港胸科服务处/英国医学研究委员会
Am Rev Respir Dis. 1991 Apr;143(4 Pt 1):700-6. doi: 10.1164/ajrccm/143.4_Pt_1.700.
9
A controlled comparison of two fully supervised once-weekly regimens in the treatment of newly diagnosed pulmonary tuberculosis.两种每周一次全程督导治疗方案用于新诊断肺结核治疗的对照比较
Tubercle. 1973 Mar;54(1):23-45. doi: 10.1016/0041-3879(73)90013-5.
10
Streptomycin plus PAS plus pyrazinamide in the retreatment of pulmonary tuberculosis in East Africa: second report. A co-operative study in East African and British Medical Research Councils.链霉素加对氨基水杨酸加吡嗪酰胺用于东非肺结核复治：第二次报告。东非医学研究委员会与英国医学研究委员会的合作研究
Tubercle. 1973 Dec;54(4):283-90. doi: 10.1016/s0041-3879(73)80031-5.

引用本文的文献

1
Examining effective monotherapy hypothesis for TB therapy failure and resistance emergence.探讨结核病治疗失败和耐药性产生的有效单药治疗假说。
Int J Tuberc Lung Dis. 2024 Dec 1;28(12):572-577. doi: 10.5588/ijtld.24.0121.
2
Failure of the azithromycin and ethambutol combination regimen in the hollow-fibre system model of pulmonary Mycobacterium avium infection is due to acquired resistance.阿奇霉素和乙胺丁醇联合治疗方案在肺鸟分枝杆菌感染的中空纤维系统模型中失败是由于获得性耐药。
J Antimicrob Chemother. 2017 Sep 1;72(suppl_2):i20-i23. doi: 10.1093/jac/dkx303.
3
Understanding pharmacokinetics to improve tuberculosis treatment outcome.
了解药代动力学以改善结核病治疗效果。
Expert Opin Drug Metab Toxicol. 2014 Jun;10(6):813-23. doi: 10.1517/17425255.2014.895813. Epub 2014 Mar 6.
4
Intermittent versus daily therapy for treating tuberculosis in children.间歇性治疗与每日治疗用于儿童结核病治疗的比较
Cochrane Database Syst Rev. 2014 Jan 28;2014(1):CD007953. doi: 10.1002/14651858.CD007953.pub2.
5
An oracle: antituberculosis pharmacokinetics-pharmacodynamics, clinical correlation, and clinical trial simulations to predict the future.一个预言：抗结核药物代谢动力学-药效学、临床相关性和临床试验模拟预测未来。
Antimicrob Agents Chemother. 2011 Jan;55(1):24-34. doi: 10.1128/AAC.00749-10. Epub 2010 Oct 11.
6
Clinical and toxicodynamic evidence that high-dose pyrazinamide is not more hepatotoxic than the low doses currently used.临床和毒动学证据表明，高剂量吡嗪酰胺的肝毒性并不比目前使用的低剂量更严重。
Antimicrob Agents Chemother. 2010 Jul;54(7):2847-54. doi: 10.1128/AAC.01567-09. Epub 2010 May 3.
7
New susceptibility breakpoints for first-line antituberculosis drugs based on antimicrobial pharmacokinetic/pharmacodynamic science and population pharmacokinetic variability.基于抗菌药物药代动力学/药效学科学和群体药代动力学变异性的一线抗结核药物新药敏断点。
Antimicrob Agents Chemother. 2010 Apr;54(4):1484-91. doi: 10.1128/AAC.01474-09. Epub 2010 Jan 19.
8
Comparative evaluation of Löwenstein-Jensen proportion method, BacT/ALERT 3D system, and enzymatic pyrazinamidase assay for pyrazinamide susceptibility testing of Mycobacterium tuberculosis.用于结核分枝杆菌吡嗪酰胺药敏试验的罗氏比例法、BacT/ALERT 3D系统和酶促吡嗪酰胺酶测定法的比较评估
J Clin Microbiol. 2007 Jan;45(1):76-80. doi: 10.1128/JCM.00951-06. Epub 2006 Nov 8.
9
Pharmacokinetic considerations in the treatment of tuberculosis in patients with renal failure.肾衰竭患者结核病治疗中的药代动力学考量
Clin Pharmacokinet. 2005;44(3):221-35. doi: 10.2165/00003088-200544030-00001.
10
Adverse effects of antituberculosis drugs.抗结核药物的不良反应。
Drugs. 1982 Jan-Feb;23(1-2):56-74. doi: 10.2165/00003495-198223010-00003.